Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam Against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii : A Genomics-Informed Mechanism-based model

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf567Source: DataRank Database

Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam Against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii : A Genomics-Informed Mechanism-based model is a research paper published in The Journal of Infectious Diseases (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.95)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Eloise Liu,Quentin Vallé ORCID,Rajnikant Sharma ORCID,Ngoc Minh Bui ORCID,Vyanka Mezcord ORCID

Live enrichment

PubMed:41223187 PMC:PMC13016800 OpenAlex:https://openalex.org/W4416148675

NIH

Grant: R01AI146241

NIH

Grant: R01AI170889

NIH

Grant: SC3GM125556

FWCI

0.95

Citation Percentile

0.8%

Citation Trend

2026

hybridLicense: cc-by-nc-nd

journalhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaf567/65277495/jiaf567.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaf567/65277495/jiaf567.pdf

publisherhttps://academic.oup.com/jid/article-pdf/233/2/e521/65277495/jiaf567.pdf

journalhttps://doi.org/10.1093/infdis/jiaf567

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41223187

Fields of Study

Antibiotic Resistance in BacteriaEvolution and Genetic DynamicsBacterial Genetics and BiotechnologyAcinetobacter baumanniiCeftazidimeAmpicillinAnti-Bacterial AgentsAzabicyclo CompoundsSulbactamDrug Combinationsbeta-LactamasesMicrobial Sensitivity TestsCarbapenemsHumansAcinetobacter InfectionsDrug Resistance, Multiple, BacterialGenomicsbeta-Lactamase Inhibitors

MeSH Terms

Acinetobacter InfectionsAmpicillinAnti-Bacterial Agentsbeta-LactamasesCeftazidimeDrug CombinationsHumansMicrobial Sensitivity TestsSulbactamCarbapenemsGenomicsDrug Resistance, Multiple, BacterialAcinetobacter baumanniiAzabicyclo Compoundsbeta-Lactamase Inhibitors

Keywords

AntibioticsAntibiotic resistanceAnti-Infective AgentsMEDLINEMicrobiological TechniquesAntimicrobial resistanceMechanism-based ModelingMetallo-β-lactamasesPharmacokinetics/pharmacodynamicsCarbapenem-resistant Acinetobacter Baumannii